Gyeonggi, South Korea

Deok-Kun Oh

This inventor holds 1 USPTO granted patent. Top assignee: Chebigen Co., Ltd.. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Deok-Kun Oh. Retrieved from https://idiyas.com/inventor/deok-kun-oh-e84n502z

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Deok-Kun Oh: Inventor of a Retinoid-Based Anti-Cancer Invention

Introduction

Deok-Kun Oh is an inventor based in Gyeonggi, South Korea. His patent work includes a retinoid derivative invention intended for potential use in cancer treatment. The available information lists 1 patent associated with him.

Latest Patents

Oh is named on the patent “Retinoid Derivatives and Methods for Producing Said Compounds and Anti-Cancer Pharmaceutical Composition Comprising Said Compounds.” The invention describes a novel retinoid derivative, its production methods, and a pharmaceutical composition containing the compound. According to the patent description, the compound is intended to provide anti-cancer effects while avoiding undesirable side effects.

Career Highlights

Oh is associated with Chebigen Co., Ltd. His listed patent reflects work on developing chemical compounds and exploring their potential pharmaceutical applications.

Collaborations

The information provided names Jong-Sup Park and Young-Soy Rho as Oh’s coworkers. Their inclusion points to a professional context involving collaboration in research and development.

Conclusion

Deok-Kun Oh’s listed patent centers on retinoid derivatives, methods for producing them, and their proposed application in an anti-cancer pharmaceutical composition.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…